2-(n-butyl)-2-ethyl pentanoic acid | 56065-62-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-(n-butyl)-2-ethyl pentanoic acid
• 英文别名: 2-ethyl-2-n-propyl-hexanoic acid；2-ethyl-2-propyl-hexanoic acid；2-Aethyl-2-propyl-hexansaeure；4-Aethyl-octan-carbonsaeure-(4)；2-Ethyl-2-n-propylhexanoic acid；2-ethyl-2-propylhexanoic acid
• CAS: 56065-62-4
• 化学式: C₁₁H₂₂O₂
• 分子量: 186.294
• InChiKey: CHRYJYGADXDCLT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  13
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(n-butyl)-2-ethyl pentanoic acid 在 氯化亚砜 作用下， 生成 2-ethyl-2-propyl-hexanoyl chloride
  参考文献：
  名称：

  Murayama, Chemical and pharmaceutical bulletin, 1958, vol. 6, p. 186,190

  摘要：

  DOI：
• 作为产物：
  描述：

  2-ethylpentanenitrile 在 盐酸 、 亚硝酸丁酯 、 硫酸 、 sodium amide 、 溶剂黄146 、 甲苯 作用下， 生成 2-(n-butyl)-2-ethyl pentanoic acid
  参考文献：
  名称：

  Murayama, Chemical and pharmaceutical bulletin, 1958, vol. 6, p. 186,190

  摘要：

  DOI：

文献信息

• Secondary amines
  申请人：Labaz

  公开号：US04201725A1

  公开（公告）日：1980-05-06

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH.dbd.CH--R.sub.6 or an alkynyl radical of the formula C.tbd.C--R.sub.6, in which R.sub.6 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.4 and R.sub.5, which are the same or different, each respresent a hydrogen atom, a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 5 carbon atoms or an .omega.-hydroxyalkyl radical containing from 2 to 5 carbon atoms or R.sub.4 and R.sub.5, when they are taken together represent an alkylene radical containing from 2 to 6 carbon atoms, an alkylidene radical containing from 1 to 5 carbon atoms or the radical --CH.sub.2 --CH.sub.2 --O--CH.sub.2 --CH.sub.2 --, R.sub.1, R.sub.2 and R.sub.3 being such that the trisubstituted methylamine radical possesses no more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.

  甲基胺衍生物的公式为：##STR1##以及药学上可接受的酸加成盐，其中R.sub.1和R.sub.3各自代表一个氢原子或一个含有1至6个碳原子的直链或支链烷基、烯基或炔基自由基，R.sub.2代表一个含有2至7个碳原子的直链或支链烷基、烯基或炔基自由基，条件是当R.sub.2代表一个公式为CH.dbd.CH--R.sub.6的烯基自由基或一个公式为C.tbd.C--R.sub.6的炔基自由基时，其中R.sub.6代表一个氢原子或一个含有1至5个碳原子的直链或支链烷基自由基，R.sub.1和R.sub.3各自代表一个氢原子或一个烷基自由基，R.sub.4和R.sub.5相同或不同，各自代表一个氢原子，一个含有1至5个碳原子的直链或支链烷基、烯基或炔基自由基，或一个含有2至5个碳原子的ω-羟基烷基自由基，或者R.sub.4和R.sub.5共同代表一个含有2至6个碳原子的亚烷基自由基，一个含有1至5个碳原子的亚烷基自由基或自由基--CH.sub.2 --CH.sub.2 --O--CH.sub.2 --CH.sub.2 --，R.sub.1、R.sub.2和R.sub.3使得三取代甲基胺自由基最多含有13个碳原子。它们可用于治疗帕金森病，并用于纠正由神经阻滞剂引起的锥体外系扰动。
• Active derivatives of methylamine in therapeutic compositions and
  申请人：Labaz

  公开号：US04057644A1

  公开（公告）日：1977-11-08

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH.dbd.CH--R.sub.6 or an alkynyl radical of the formula C.tbd.C--R.sub.6, in which R.sub.6 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.4 and R.sub.5, which are the same or different, each represent a hydrogen atom, a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 5 carbon atoms or an .omega.-hydroxyalkyl radical containing from 2 to 5 carbon atoms or R.sub.4 and R.sub.5, when they are taken together represent an alkylene radical containing from 2 to 6 carbon atoms, an alkylidene radical containing from 1 to 5 carbon atoms or the radical --CH.sub.2 --CH.sub.2 --O--CH.sub.2 --CH.sub.2 --, R.sub.1, R.sub.2 and R.sub.3 being such that the trisubstituted methylamine radical possesses no more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH.dbd.CH--R.sub.6 or an alkynyl radical of the formula C.tbd.C--R.sub.6, in which R.sub.6 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.4 and R.sub.5, which are the same or different, each represent a hydrogen atom, a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 5 carbon atoms or an .omega.-hydroxyalkyl radical containing from 2 to 5 carbon atoms or R.sub.4 and R.sub.5, when they are taken together represent an alkylene radical containing from 2 to 6 carbon atoms, an alkylidene radical containing from 1 to 5 carbon atoms or the radical --CH.sub.2 --CH.sub.2 --O--CH.sub.2 --CH.sub.2 --, R.sub.1, R.sub.2 and R.sub.3 being such that the trisubstituted methylamine radical possesses no more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.
• Active derivatives of methylamine, therapeutic compositions containing
  申请人：Labaz

  公开号：US04026925A1

  公开（公告）日：1977-05-31

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH=CH--R.sub.4 or an alkynyl radical of the formula C.tbd.C--R.sub.4, in which R.sub.4 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.1, R.sub.2 and R.sub.3 being such that no compound of formula I possesses more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.

  甲基胺衍生物的化学式为：##STR1##及其药用可接受的酸盐，其中R.sub.1和R.sub.3分别表示氢原子或含有1至6个碳原子的直链或支链烷基、烯基或炔基基团，R.sub.2表示含有2至7个碳原子的直链或支链烷基、烯基或炔基基团，但当R.sub.2表示化学式CH=CH--R.sub.4的烯基基团或化学式C.tbd.C--R.sub.4的炔基基团时，其中R.sub.4表示氢原子或含有1至5个碳原子的直链或支链烷基基团，R.sub.1和R.sub.3各自表示氢原子或烷基基团，R.sub.1、R.sub.2和R.sub.3使得化合物I的碳原子数不超过13个。它们可用于治疗帕金森病和纠正由神经阻滞剂引起的额外锥体外运动障碍。
• Active derivatives of methylamino in therapeutic compositions and
  申请人：Labaz

  公开号：US04048334A1

  公开（公告）日：1977-09-13

  Methylamine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.3 each represent a hydrogen atom or a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 1 to 6 carbon atoms, R.sub.2 represents a straight- or branched-chain alkyl, alkenyl or alkynyl radical containing from 2 to 7 carbon atoms with the proviso that when R.sub.2 represents an alkenyl radical of the formula CH.tbd.CH--R.sub.4 or an alkynyl radical of the formula C=C--R.sub.4, in which R.sub.4 represents a hydrogen atom or a straight- or branched-chain alkyl radical of 1 to 5 carbon atoms, R.sub.1 and R.sub.3 each represent an atom of hydrogen or an alkyl radical, R.sub.1, R.sub.2 and R.sub.3 being such that no compound of formula I possesses more than 13 carbon atoms. They are useful for treating Parkinson's disease and for correcting extra-pyramidal disturbances provoked by neuroleptics.

  化学式为##STR1##的甲基胺衍生物及其药学上可接受的酸盐，其中R.sub.1和R.sub.3分别表示氢原子或含有1至6个碳原子的直链或支链烷基、烯基或炔基基团，R.sub.2表示含有2至7个碳原子的直链或支链烷基、烯基或炔基基团，但当R.sub.2表示公式CH.tbd.CH--R.sub.4的烯基基团或公式C=C--R.sub.4的炔基基团，其中R.sub.4表示氢原子或含有1至5个碳原子的直链或支链烷基基团时，R.sub.1和R.sub.3分别表示氢原子或烷基基团，R.sub.1、R.sub.2和R.sub.3的选择使得公式I的化合物中不含有超过13个碳原子。它们可用于治疗帕金森病并纠正由神经类药物引起的额外锥体外运动障碍。
• Katalysator, dessen Herstellung und Verwendung zur Lösungspolymerisation von konjugierten Dienen
  申请人：BAYER AG

  公开号：EP0011184A1

  公开（公告）日：1980-05-28

  Ein Katalysator, bestehend aus A) einem Carboxylat der Seltenen Erden der Formel B) einem Aluminiumalkyl AlR43 und/oderR42AlH C) einer Lewissäure, wobei M ein dreiwertiges Element der Seltenen Erden mit den Ordnungszahlen 57 bis 71, R1,R2 und R' gleich oder verschieden Alkylreste mit 1 bis 10 Kohlenstoffatomen, wobei die Summe aller C-Atome in den Substituenten 6 bis 20 beträgt, und R4 einen Alkylrest mit 1 bis 10 Kohlenstoffatomen bedeuten, kann zur Lösungspolymerisation von Butadien eingesetzt werden. Es wird hergestellt, indem man die Komponenten A, B und C in einem inerten organischen Lösungsmittel bei Temperaturen von -30 bis 80°C in beliebiger Reihenfolge mischt.

  一种由 A）式中的稀土羧酸盐 B）铝烷基 AlR43 和/或 R42AlH C）路易斯酸组成的催化剂可用于丁二烯的溶液聚合，其中 M 是原子序数为 57 至 71 的三价稀土元素，R1、R2 和 R'是具有 1 至 10 个碳原子的相同或不同的烷基，取代基中所有 C 原子的总和为 6 至 20，R4 是具有 1 至 10 个碳原子的烷基。 其制备方法是在-30 至 80°C 的温度下，在惰性有机溶剂中以任何所需的顺序混合 A、B 和 C 组份。